Cause of Death in Follicular Lymphoma in the First Decade of the Rituximab Era: A Pooled Analysis of French and US Cohorts

Overview of attention for article published in Journal of Clinical Oncology, November 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news: 4 news outlets
policy: 1 policy source
twitter: 23 X users

patent: 7 patents
guideline: 1 clinical guideline source

Readers on

mendeley: 143 Mendeley

So far, Altmetric has seen 2 policy documents that reference this research output.

axicabtagene ciloleucel - Clinical, Pharmacoeconomic and Ethics combined Report

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 14 Feb 2023

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

tisagenlecleucel - Clinical, Pharmacoeconomic, Ethics, and Stakeholder Input Combined Report

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 21 Nov 2022

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.